| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04010 |
MAPK signaling pathway |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04020 |
Calcium signaling pathway |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04022 |
cGMP-PKG signaling pathway |
| 4. Cellular Processes |
4.2 Cell growth and death |
hsa04114 |
Oocyte meiosis |
| 4. Cellular Processes |
4.2 Cell growth and death |
hsa04218 |
Cellular senescence |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04310 |
Wnt signaling pathway |
| 5. Organismal Systems |
5.8 Development |
hsa04360 |
Axon guidance |
| 3. Environmental Information Processing |
3.2 Signal transduction |
hsa04370 |
VEGF signaling pathway |
| 5. Organismal Systems |
5.8 Development |
hsa04380 |
Osteoclast differentiation |
| 5. Organismal Systems |
5.1 Immune system |
hsa04625 |
C-type lectin receptor signaling pathway |
| 5. Organismal Systems |
5.1 Immune system |
hsa04650 |
Natural killer cell mediated cytotoxicity |
| 5. Organismal Systems |
5.1 Immune system |
hsa04658 |
Th1 and Th2 cell differentiation |
| 5. Organismal Systems |
5.1 Immune system |
hsa04659 |
Th17 cell differentiation |
| 5. Organismal Systems |
5.1 Immune system |
hsa04660 |
T cell receptor signaling pathway |
| 5. Organismal Systems |
5.1 Immune system |
hsa04662 |
B cell receptor signaling pathway |
| 5. Organismal Systems |
5.6 Nervous system |
hsa04720 |
Long-term potentiation |
| 5. Organismal Systems |
5.6 Nervous system |
hsa04724 |
Glutamatergic synapse |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04921 |
Oxytocin signaling pathway |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04922 |
Glucagon signaling pathway |
| 5. Organismal Systems |
5.2 Endocrine system |
hsa04924 |
Renin secretion |
| 6. Human Diseases |
6.4 Neurodegenerative diseases |
hsa05010 |
Alzheimer disease |
| 6. Human Diseases |
6.4 Neurodegenerative diseases |
hsa05014 |
Amyotrophic lateral sclerosis (ALS) |
| 6. Human Diseases |
6.5 Substance dependence |
hsa05031 |
Amphetamine addiction |
| 6. Human Diseases |
6.8 Infectious diseases: Bacterial |
hsa05152 |
Tuberculosis |
| 6. Human Diseases |
6.9 Infectious diseases: Viral |
hsa05163 |
Human cytomegalovirus infection |
| 6. Human Diseases |
6.9 Infectious diseases: Viral |
hsa05166 |
Human T-cell leukemia virus 1 infection |
| 6. Human Diseases |
6.9 Infectious diseases: Viral |
hsa05167 |
Kaposi sarcoma-associated herpesvirus infection |
| 6. Human Diseases |
6.9 Infectious diseases: Viral |
hsa05170 |
Human immunodeficiency virus 1 infection |
| 6. Human Diseases |
6.1 Cancers: Overview |
hsa05235 |
PD-L1 expression and PD-1 checkpoint pathway in cancer |